Physician profile
Mark Michael D'Onofrio
NPI 1316925811
$158,645.76
in general payments reported to CMS, 2019-2025
31 companies · $62K in 2025
The $62K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,203 · 2020: $2,501 · 2021: $16K · 2022: $19K · 2023: $47K · 2024: $9,306 · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $87K · Consulting Fee: $21K · Travel and Lodging: $5,456 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Food and Beverage: $2,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $86,693.41 |
| Consulting Fee | $20,787.50 |
| Travel and Lodging | $5,455.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Food and Beverage | $2,604.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Signature Orthopaedics USA Corp | $93,899.59 | 2020-2025 | |
| Fx Shoulder Solutions, INC | $29,636.82 | 2019-2025 | Humelock Reversed Shoulder |
| Globus Medical, INC. | $26,359.88 | 2020-2025 | Genflex2 Total Knee System, Legacy Stelkast Knee, Actify 3d |
| Corentec America INC | $4,703.00 | 2023-2025 | Corentec |
| Ortho Development Corporation | $2,743.34 | 2019-2025 | |
| Maxx Orthopedics, INC. | $163.40 | 2019 | |
| Catalyst Orthoscience | $101.35 | 2021 | |
| Heron Therapeutics, INC. | $90.17 | 2021-2024 | Zynrelef |
| Stimwave Technologies Incorporated | $85.45 | 2019 | |
| Endo Pharmaceuticals INC. | $75.45 | 2020-2022 | |
| Abbott Laboratories | $73.72 | 2022-2024 | Proclaim |
| Nextstep Arthropedix, LLC | $67.63 | 2020 | |
| Pacira Therapeutics, INC. | $62.76 | 2019-2020 | |
| Depuy Synthes Sales INC. | $61.06 | 2019 | |
| Convatec INC. | $52.00 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $50.23 | 2023-2025 | Zilretta, Iovera, Exparel |
| Shalby Advanced Technologies, INC. | $49.67 | 2021 | |
| Orthofix Medical, INC. | $38.90 | 2022 | |
| Smith+Nephew, INC. | $35.78 | 2019-2020 | |
| Cosa Medical, LLC | $32.99 | 2025 | |
| Avanos Medical | $31.36 | 2022-2023 | On-Q* Pump and Accessories |
| Abbvie INC. | $30.33 | 2024 | |
| Bioventus LLC | $30.19 | 2019-2023 | Durolane |
| Heraeus Medical, LLC. | $28.65 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $27.48 | 2019-2023 | Euflexxa |
| Endo USA, INC. | $24.68 | 2025 | Xiaflex |
| Si-Bone, INC. | $22.50 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $20.24 | 2025 | |
| Boston Scientific Corporation | $18.66 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.00 | 2019 | |
| Medtronic, INC. | $13.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark D'Onofrio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.